CytoGenX Corporation – Trademark Portfolio

Entity Type: 03

CytoGenX Corporation holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PREVIEW and PREVIEW PLUS. The owner is based in Stony Brook, NY.

1212 North Country Road

Stony Brook, NY 11790

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CYTOGENX
CYTOGENX
Abandoned 2025
ASSURE
ASSURE
Abandoned 2025
PREVIEW
PREVIEW
Registered 2025

Trademark Classifications

CytoGenX Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does CytoGenX Corporation have?

CytoGenX Corporation has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does CytoGenX Corporation file in?

CytoGenX Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are CytoGenX Corporation's most well-known trademarks?

CytoGenX Corporation's registered trademark portfolio includes well-known marks such as PREVIEW and PREVIEW PLUS. These are among 2 currently registered trademarks in the portfolio.

What is CytoGenX Corporation's trademark registration success rate?

CytoGenX Corporation has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.